Organoids and Spheroids Market to Reach USD 11.94 Billion by 2035, Propelled by Surging Demand for Advanced 3D Cell Culture Models and Precision Medicine Expansion – SNS Insider

AI Briefing

• – The organoids and spheroids market is expected to reach USD 11.94 billion by 2035.
• – Advancements in CRISPR gene editing, AI-based drug screening, and patient-derived organoid platforms are driving growth.
• – These technologies are transforming biomedical research and pharmaceutical drug discovery globally.